Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
Authors:
Open Access
- 25 October 2022
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 45 (11) , 2729-2736
Abstract
OBJECTIVE: N-glycosylation is a functional posttranslational modification of immunoglobulins (Igs). We hypothesized that specific IgG N-glycans are associated with incident type 2 diabetes and cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS: We performed case-cohort studies within the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam cohort (2,127 in the type 2 diabetes subcohort [741 incident cases]; 2,175 in the CVD subcohort [417 myocardial infarction and stroke cases]). Relative abundances of 24 IgG N-glycan peaks (IgG-GPs) were measured by ultraperformance liquid chromatography, and eight glycosylation traits were derived based on structural similarity. End point–associated IgG-GPs were preselected with fractional polynomials, and prospective associations were estimated in confounder-adjusted Cox models. Diabetes risk associations were validated in three independent studies. RESULTS: After adjustment for confounders and multiple testing correction, IgG-GP7, IgG-GP8, IgG-GP9, IgG-GP11, and IgG-GP19 were associated with type 2 diabetes risk. A score based on these IgG-GPs was associated with a higher diabetes risk in EPIC-Potsdam and independent validation studies (843 total cases, 3,149 total non-cases, pooled estimate per SD increase 1.50 [95% CI 1.37–1.64]). Associations of IgG-GPs with CVD risk differed between men and women. In women, IgG-GP9 was inversely associated with CVD risk (hazard ratio [HR] per SD 0.80 [95% CI 0.65–0.98]). In men, a weighted score based on IgG-GP19 and IgG-GP23 was associated with higher CVD risk (HR per SD 1.47 [95% CI 1.20–1.80]). In addition, several derived traits were associated with cardiometabolic disease incidence. CONCLUSIONS: Selected IgG N-glycans are associated with cardiometabolic risk beyond classic risk factors, including clinical biomarkers.Keywords
All Related Versions
Funding Information
- Lemann Foundation
- European Union (05F02, SOC 95201408)
- Federal Ministry of Science, Germany (EA 9401)
- European Structural and Investment Funds: Research and Development (KK.01.2.1.01.0003)
- German Research Foundation (WI5132/1-1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK112940)
- National Heart Lung and Blood Institute (HL 117861, K24 HL136852, R01 HL134811)
- Croatian National Centre of Research Excellence (KK.01.1.1.01.0010)
- Centre of Competence (KK.01.2.2.03.0006)
- German Ministry of Education and Research (BMBF) and State of Brandenburg (82DZD00302, 82DZD03D03)
- European Community (05F02, SOC 98200769)
- German Cancer Aid (70-2488-Ha)
- SciLifeLab & Wallenberg Data Driven Life Science Program (KAW 2020.0239)
- Horizon 2020 (721815)
- Horizon 2020 (722095)
This publication has 38 references indexed in Scilit:
- Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1Nature Medicine, 2012
- High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human PopulationsMolecular & Cellular Proteomics, 2011
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathwayNature, 2011
- Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc SialylationScience, 2006
- Dietary and Genetic Control of Glucose Transporter 2 Glycosylation Promotes Insulin Secretion in Suppressing DiabetesCell, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation, 2003
- Inflammation in atherosclerosisNature, 2002
- Recruitment Procedures of EPIC-GermanyAnnals of Nutrition and Metabolism, 1999
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993